Neuronetics (STIM) Net Income towards Common Stockholders (2017 - 2025)
Neuronetics (STIM) has disclosed Net Income towards Common Stockholders for 9 consecutive years, with -$9.2 million as the latest value for Q3 2025.
- On a quarterly basis, Net Income towards Common Stockholders rose 1.89% to -$9.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$45.1 million, a 29.87% decrease, with the full-year FY2024 number at -$41.8 million, down 16.32% from a year prior.
- Net Income towards Common Stockholders was -$9.2 million for Q3 2025 at Neuronetics, up from -$10.0 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$6.8 million in Q4 2023 to a low of -$13.2 million in Q4 2024.
- A 5-year average of -$9.5 million and a median of -$9.2 million in 2025 define the central range for Net Income towards Common Stockholders.
- Biggest YoY gain for Net Income towards Common Stockholders was 33.6% in 2021; the steepest drop was 138.62% in 2021.
- Neuronetics' Net Income towards Common Stockholders stood at -$8.2 million in 2021, then decreased by 7.19% to -$8.8 million in 2022, then increased by 23.52% to -$6.8 million in 2023, then plummeted by 95.96% to -$13.2 million in 2024, then skyrocketed by 30.82% to -$9.2 million in 2025.
- Per Business Quant, the three most recent readings for STIM's Net Income towards Common Stockholders are -$9.2 million (Q3 2025), -$10.0 million (Q2 2025), and -$12.7 million (Q1 2025).